AFLD 2010 FFHB vs Respondent M44

2 Sep 2010

Facts
The French Handball Federation (Fédération Française de Handball, FFHB) charges respondent M44 or a violation of the Anti-Doping Rules. During a match on December 5, 2009, a sample was taken for doping test purposes. The analysis of the sample showed the presence of a metabolite of cannabis above the threshold value. Cannabis is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list. Cannabis is regarded as a specified substance.

History
The initial decision, dated March 23, 2010, by the disciplinary committee of the FFHB is a period of ineligibility of three months. Respondent admits using the prohibited substance occasionally but there was no intention to enhance sport performance.

Decision
1. The sanction is a period of ineligibility of six months in which respondent can't take part in competition or manifestation organized or authorized by the FFHB.
2. The decision, dated March 23, 2010, of the disciplinary committee of the FFHB should be modified.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

CAS 2013_A_3395 Anderson Luís De Souza ("Deco") vs CBF & FIFA - Settlement

26 May 2014

CAS 2013/A/3395 Anderson Luis de Souza v. Confederação Brasileira de Futebol (CBF) & Fédération Internationale de Football Association (FIFA), consent award of 26 May 2014

Football
Doping
Authority of an arbitral tribunal to issue a consent award under Swiss law
Control of the bona fide nature of the settlement agreement by the arbitral tribunal in a consent award
Legal nature of the Superior Tribunal de Justiça Desportiva do Futebol (STJD)

1. Under Swiss Law, an arbitration tribunal has authority to issue an award embodying the terms of the parties’ settlement, if the contesting parties agree to a termination of their dispute in this manner. The panel’s ratification of their settlement and its incorporation into a consent award serves the purpose of enabling the enforcement of their agreement.

2. It is the task of the arbitrator to verify the bona fide nature of the settlement agreement, to ensure that the will of the parties has not been manipulated by them to commit fraud and to confirm that the terms of the settlement agreement are not contrary to public policy principles or mandatory rules of the law applicable to the dispute.

3. The STJD is a justice body which is an integral part of the organizational structure of the CBF, with no legal personality of its own and (at least) for international purposes the decisions of the STJD, although independently reached, must be considered to be the decisions of the CBF. As a result, the STJD has no autonomous legal personality and may not be considered as respondent on its own in a CAS appeal arbitration concerning one of its rulings; consequently, the procedural position of the STJD before the CAS must be encompassed within that of the CBF. Against this background, the fact that the STJD was not called as a party to the proceedings does not affect the validity nor the enforceability of a subsequent settlement agreement and of a consent award.


In April 2013 the Confederaçãoo Brasileira de Futebol (CBF), the Brazilian Football Confederation, has reported an anti-doping rule violation against the Portuguese football player Anderson Luís De Souza after his sample tested positive for the prohibited substances hydrochlorothiazide and tamoxifen.
On 14 June 2013 the Regional Commission of the Brazilian Sports Court of Football in Rio de Janeiro (TJD/RJ) decided to impose a 30 day period of ineligibility on the Player, starting on the date of the provisional suspension.

Hereafter both the Player and the TJD/RJ Procecutor appealed this decision with the Superior Tribunal de Justiça Desportiva do Futebol (STJC), the Brazilian High Sports Court of Football.
On 26 September the STJC decided to impose a 1 year period of ineligibility on the Player.

After rejection of the Player’s objections against the STJC decision, the Player appealed this decision with the Court of Arbitration for Sport (CAS) in november 2013.

The Player submitted that the decision issued by the STJD was based on an adverse analytical finding indicating the presence of the substances in his samples, analyzed by the (former) WADA-accredited laboratory LADETEC, but that there were serious doubts concerning the validity and accuracy of the test itself, as well as with regard to the International Standard of Laboratories (ISL), issued by the World Anti-Doping Agency (WADA).
In particular, the Player stated that the LADETEC had its accreditation revoked by WADA in August 2013 and that consequently, there was no certainty as to whether the test conducted on the Player’s sample was accurate and in respect of the ISL.
In addition, the Player argued that FIFA had decided, together with WADA, to use the WADA-accredited laboratory in Lausanne, Switzerland, to analyze blood and urine samples, to be taken on the occasion of the upcoming 2014 FIFA World Cup in Brazil, which, according to the Appellant, demonstrated that an analysis conducted by LADETEC may not be considered reliable.

Accordingly the Player argued that as serious doubts existed as to the accuracy of the adverse analytical finding reported by LADETEC on his samples, the Player requested to ask FIFA to submit the documentation packages related to both his A and B samples to the attention of an expert of its choice, possibly Mr. Martial Saugy, Director of the WADA-accredited laboratory in Lausanne, and to request another laboratory of its choice, possibly the WADA-accredited laboratory in Lausanne, for additional sample analysis regarding his A and B samples.

On 2 December 2013 FIFA informed the CAS that, based on the recent suspension of the laboratory in Rio de Janeiro, it had asked Mr. Martial Saugy, Director of the WADA-accredited laboratory in Lausanne, to analyse the documentation package related to the Player’s A and B-sample. The results of the analyses made by Mr. Saugy led him to inform FIFA, on the 18 October 2013 that "Because of the non-proved identification of Tamoxifen, we suggest to FIFA Medical Office to be very careful with this adverse analytical finding made by the Rio laboratory."
On the 03 December 2013 all the Parties finally agreed to the suspension of the proceedings pending a retesting of the Player's A and B samples.

On 6 March 2014, FIFA addressed a letter to the CAS informing that the results of such a retesting conducted by the laboratory in Lausanne, according to which "No Prohibited Substance(s) or Metabolite(s) or Marker(s) of a Prohibited Method(s) on the test menu were detected."
In addition, the Doping Control Report, signed by Mr. Saugy, further affirmed that "After further investigation, traces of hydrochlorothiazide were found at level below the limit of detection of the initial testing procedure. The sample was received in unusual container. The chain of custody can not be guaranteed".

Finally, and particularly in view of said results, all of the Parties have agreed, in the context of the afore-mentioned CAS proceedings, to sign an agreement which shall be incorporated within a Consent Award; and thus it is agreed between the parties with their consent:

1.) The Appeal filed by Mr. Anderson Luís de Souza is upheld.
2.) The Appealed Decision is set aside.
3.) It could not be established that Mr. Anderson Luís de Souza has committed an anti-doping rule violation.
4.) The arbitration costs, to be determined and served by the CAS Court Office in due course, shall be borne by the Appellant Mr. Anderson Luís de Souza.
5.) Each party shall bear their own legal and other costs incurred in connection with the present proceedings.
6.) The parties request the panel to issue a Consent Award reflecting the terms of this agreement.
7.) The Consent Award and a press release setting forth the results of the proceedings shall be made public by CAS.
8.) With the execution of the present agreement the parties declare themselves reciprocally settled and with no right whatsoever to claim anything against the other party.

Therefore the Court of Arbitration for Sports rules:

1.) The Settlement Agreement executed by the Player Mr Anderson Luís De Souza, the Confederação Brasileira de Futebol (CBF) and the Fédération Internationale de Football Association (FIFA) on 20 March 2014 is hereby ratified by the CAS with the consent of the Parties, and its terms are incorporated into this arbitral award.
2.) The terms of the Settlement Agreement dated 20 March 2014 replace the decision of the Superior Tribunal de Justiça Desportiva de Futebol of 26 September 2013.
3.) The costs of the present arbitration, which shall be determined and separately communicated to the Parties by the CAS Court Office, shall be borne by the Appellant.
4.) Each party shall bear all of its respective legal and other costs incurred in connection with this arbitration.
5.) All other or further claims are dismissed.

AFLD 2010 FFBB vs Respondent M43

2 Sep 2010

Facts
The French Basketball Federation (Fédération Française de Basket-Ball, FFBB) charges respondent M43 for a violation of the Anti-Doping Rules. During a match on October 24, 2009, a sample was taken for doping test purposes. The analysis of the sample showed the presence of a metabolite of cannabis. Cannabis is prohibited according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The sanction, dated January 6, 2010, by the disciplinary committee of the committee is disqualification from participation for four meetings at competitions and events organized sports or authorized by FFBB. However the respondent didn't give any information about how the prohibited substance had entered his body.

Decision
1. The sanction is a period of ineligibility of six months in which respondent is excluded from competition for four times.
2. The decision, dated January 6, 2010, by the disciplinary committee of the FFBB should be modified.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

AFLD 2010 FFTir vs Respondent M42

18 Feb 2010

Facts
The French Shooting Federation (Fédération Française de Tir, FFTir) charges respondent M42 for a violation of the Anti-Doping Rules. During a shooting contest, on November 28, 2009, a sample for doping test purposes was taken. The sample tested positive on hydrochlorothiazide and bisoprolol which is a prohibited substance on the World Anti-Doping Agency (WADA) prohibited list. Hydrochlorothiazide and bisoprolol are regarded as a specified substances.

History
The respondent used the prohibited to treat arterial hypertension and Ankylosing spondylitis (Bechterew's desease) he has certificates to prove his medication and his cardiology.

Decision
1. The respondents is acquitted.
2. The decision (two months of ineligibility), dated March 6, 2010, by the disciplinary committee of the FFTir should be modified.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

AFLD 2010 FFR vs Respondent M41

24 Jun 2010

Facts
The French Rugby Federation (Fédération Française de Rugby, FFR) charges respondent M41 for a violation of the Anti-Doping Rules. Respondent didn't comply for a doping control.

History
The disciplinary committee of the FFR had decided on February 18, 2010, that the respondent was acquitted. The sampler collector hadn't used all his available means to perform the doping control.

Decision
1. The respondent is acquitted.
2. The decision, dated February 18, 2010, of the disciplinary committee of the FFR is upheld.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

AFLD 2010 FFR vs Respondent M40

3 Jun 2010

Facts
The French Rugby Federation (Fédération Française de Rugby, FFR) charges respondent M40 for a violation of the Anti-Doping Rules. During a match on December 5, 2009, a sample was taken for doping test purposes. The analysis showed the presence of salbutamol. Salbutamol is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The disciplinary committee of the FFR had decided on February 16, 2010, that the respondent was acquitted for the reason "no significant fault or negligence. Respondent had used an inhaler to treat rhino-sinusitis and the beginning of pulmonary disease. Also he uses it to prevent an asthma attack. However the respondent has not been able to produce a complete record of clinical and complementary examinations, nor even transmitted a medical prescription which shows the usage of salbutamol.

Decision
1. The sanction is a period of ineligibility of two months, in which respondent can't take part in competition or manifestations organized or authorized by the FFR.
2. The decision (acquittal), dated February 16, 2010, by the disciplinary committee of the FFR should be modified.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

Rapid detection of erythropoiesis-stimulating agents in urine and serum

23 May 2011

Rapid detection of erythropoiesis-stimulating agents in urine and serum / M. Lönnberg, M. Andrén, G. Birgegård, M. Drevin, M. Garle, J. Carlsson. - (Analytical biochemistry (2012) 420 (15 January) : p. 101-114) doi: 10.1016/j.ab.2011.09.021. Epub 2011 Sep 29.

A rapid and easy-to-use test kit, EPO WGA MAIIA, which can be used for distinguishing various endogenous human erythropoietins (hEPOs) and several recombinant hEPO and EPO analogues, has been evaluated. The test is based on chromatographic separation of the glycosylated isoforms of EPO using wheat germ agglutinin (WGA) and a sensitive immunoassay using anti-EPO carbon black nanostrings and image scanning for quantification. All of the reactions take place along the porous layer of a lateral flow microcolumn containing WGA and anti-EPO zones. The presence of molecules resembling hEPOs, such as Mircera, was detected by the aberrant affinity interaction with the antibody zone on the strip. It was possible to distinguish nine recombinant hEPOs expressed in hamster and human cell lines, as well as Aranesp and Mircera, from endogenous urine hEPO. The required amount of EPO in the samples, a few picograms, is very low compared with other methods for EPO isoform identification. This EPO isoform determination method opens the possibility to monitor recombinant EPO therapy for clinical research and seems to be a valuable candidate to the arsenal of EPO doping control tests.

Oxygen gas-filled microparticles provide intravenous oxygen delivery

27 Jun 2012

Oxygen gas-filled microparticles provide intravenous oxygen delivery / J.N. Kheir, L.A. Scharp, M.A. Borden, E.J. Swanson, A. Loxley, J.H. Reese, K.J. Black, L.A. Velazquez, L.M. Thomson, Brian K. Walsh, Kathryn E. Mullen, Dionne A. Graham, Michael W. Lawlor, Carlo Brugnara, David C. Bell, FX McGowan Jr. – (Science translational medicine 4 (2012) 140 (27 June) : p. 1-10) doi: 10.1126/scitranslmed.3003679.

We have developed an injectable foam suspension containing self-assembling, lipid-based microparticles encapsulating a core of pure oxygen gas for intravenous injection. Prototype suspensions were manufactured to contain between 50 and 90 ml of oxygen gas per deciliter of suspension. Particle size was polydisperse, with a mean particle diameter between 2 and 4 μm. When mixed with human blood ex vivo, oxygen transfer from 70 volume % microparticles was complete within 4 s. When the microparticles were infused by intravenous injection into hypoxemic rabbits, arterial saturations increased within seconds to near-normal levels; this was followed by a decrease in oxygen tensions after stopping the infusions. The particles were also infused into rabbits undergoing 15 min of complete tracheal occlusion. Oxygen microparticles significantly decreased the degree of hypoxemia in these rabbits, and the incidence of cardiac arrest and organ injury was reduced compared to controls. The ability to administer oxygen and other gases directly to the bloodstream may represent a technique for short-term rescue of profoundly hypoxemic patients, to selectively augment oxygen delivery to at-risk organs, or for novel diagnostic techniques. Furthermore, the ability to titrate gas infusions rapidly may minimize oxygen-related toxicity.

AFLD 2010 FFR vs Respondent M39

3 Jun 2010

Facts
The French Rugby Federation (Fédération Française de Rugby, FFR) charges respondent M39 for a violation of the Anti-Doping Rules. During a match on November 24, 2009, a sample was taken for doping test purposes. The analysis of the sample showed the presence of a metabolite of cannabis. Cannabis is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent uses the prohibited substance occasionally in the evenings among friends. The reason why he uses it is related to personal difficulties: pregnant girlfriend, separation of his parents and the illness of his mother. There was no intention to enhance his sport performance.

Decision
1. The decision, dated January 26, 2009, by the disciplinary committee of the FFR should be upheld, which conflicts with a ban on participation respectively for three months and four months for competitions and manifestations organized or authorized by the FFR.
2. The decision will start on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2010 FFBB vs Respondent M38

3 Jun 2010

Facts
The French Basketball Federation (Fédération Française de Basket-Ball, FFBB) charges respondent M38 for a violation of the Anti-Doping Rules. During a match on October 24, 2009, a sample was taken for doping test purposes. The analysis of the sample showed the presence of a metabolite of cannabis. Cannabis is prohibited according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent had used cannabis in a recreational setting. There was no intention to enhance sport performance.

Decision
1. The sanction is a period of ineligibility of four months in which respondent can't take part in competition or manifestation organized by the FFBB.
2. The decision (3 months period of ineligibility), dated January 27, 2010, by the disciplinary committee of the FFBB should be modified. The period already served leaves a remaining time period of 30 hours.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin